Inferior Vena Cava Filters in Patients with Acute Pulmonary Embolism and Cancer.

Link to article at PubMed

Related Articles

Inferior Vena Cava Filters in Patients with Acute Pulmonary Embolism and Cancer.

Am J Med. 2017 Nov 10;:

Authors: Stein PD, Matta F, Lawrence FR, Hughes MJ

Abstract
BACKGROUND: Administrative data has shown a lower mortality in hospitalized patients with pulmonary embolism and cancer who receive a vena cava filter. In the absence of a randomized controlled trial of vena cava filters in such patients, further investigation is necessary. Therefore, we performed this investigation using administrative data from a different database than used previously, and we investigate patients hospitalized in more recent years.
METHODS: We analyzed administrative data from the Premier Healthcare Database, 2010-2014, in patients hospitalized with pulmonary embolism and solid malignant tumors. Patients were identified on the basis of International Classification of Disease-9(th) Clinical Modification (ICD-9-CM) codes.
RESULTS: Patients >aged 60 years had a lower in-hospital all-cause mortality with vena cava filters than those who did not have filters, 346 of 4,648 (7.4%) compared with 2,216 of 19,847 (11.2%) (P<0.0001) (relative risk 0.67). Among patients >aged 60 years who received an inferior vena cava, all-cause mortality within 3 months was 704 of 4648 (15.1%) compared with 3444 of 19,847(17.4%) among those who did not receive a filter (P<0.0001) (relative risk 0.86).
CONCLUSION: Elderly patients with pulmonary embolism and cancer may be a special population in whom inferior vena cava filters reduce in-hospital all-cause mortality. Further investigation is needed, particularly in younger patients.

PMID: 29132839 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.